期刊文献+

结核分枝杆菌Rv3369基因的表达和纯化 被引量:1

Expression and purification of Rv3369 of Mycobacterium tuberculosis
下载PDF
导出
摘要 在大肠杆菌中高效表达结核分枝杆菌Rv3369蛋白,获得纯化的重组蛋白rRv3369。通过聚合酶链反应(Polymerase chain reaction,PCR)扩增Rv3369基因;以质粒pET28a为表达载体,构建重组质粒,转化大肠杆菌BL21(DE3);以异丙基硫代半乳糖苷(IPTG)诱导表达目的蛋白,通过SDS-PAGE鉴定rRv3369在大肠杆菌中的表达,确定rRv3369在大肠杆菌中的表达形式;采用Ni-NTA His.Bind Resin来纯化重组蛋白。重组质粒pET28a-Rv3369中目的基因测序结果与报道序列相同。分子量约19.5kDa,表达量约占菌体总蛋白的18%,纯化后的重组蛋白样品经SDS-PAGE和激光密度扫描分析表明其纯度为90%以上,每100mL培养菌可获得1.56mg左右的重组蛋白。用亲和层析法纯化的重组蛋白纯度较好。 To obtain purified recombinant Rv3369 protein by means of expressing the Rv3369 protein of Mycobacterium tuberculosis in E. coli. The gene coding Rv3369 protein was amplified by polymerase chain reaction (PCR), then was inserted into an expression vector pET28a to get recombinant plasmid. The recombinant plasmid was transformed into E. coli BL21 (DE3)and induced by IPTG. The expressed product was indentified by SDS-PAGE and purified by Ni- NTA His· Bind Resin. The sequence of Rv3369 in recombinant plasmid was the same with GenBank's report. The molecular mass of the product is 19.5kDa, which accounts for about 20% in the thalli proteins, and its purity is more than 90% analyzed by SDS-PAGE and laser scanning. The yield of recombinant protein is 1.56mg from 100mL of culture. Compared with other methods, purity of the recombinant protein is higher through affinity chromatography.
出处 《微生物学报》 CAS CSCD 北大核心 2006年第5期835-837,共3页 Acta Microbiologica Sinica
基金 国家十五攻关项目(2004BA705B03)~~
关键词 结核分枝杆菌 Rv3369 基因表达 Mycobacterium tuberculosis Rv3369 Gene expression
  • 相关文献

参考文献15

  • 1Dye C,Scheele S,Dolin P,et al.Global burden of tuberculosis:estimated incidence,prevalence,and mortality by country.JAMA,1999,282:677-686.
  • 2Johnson BJ,Estrada I,Shen Z,et al.Differential gene expression in response to adjunctive recombinant human interleuin-2 immunotherapy in mutlidrug-resistent tuberculosis patients.Infect Immun,1998,66:2425-2433.
  • 3Hirel PH,Schmitter MJ,Dessen P,et al.Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid.Proc Natl Acad Sci USA,1989,86:8247-8251.
  • 4彭丽,罗永艾.结核病的实验室快速诊断[J].新医学,2005,36(6):359-361. 被引量:28
  • 5Gay AV,Jamil S,Drews SJ.Expression and characterization of the Mycobacterium tuberculosis serine/threonine protein kinase PKnB.Infect Immun,1999,67:5676-5682.
  • 6Berthet FX,Rasmussen PB,Rosenkrands I,et al.A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10).Microbiology,1998,144(pt 11):3195-3203.
  • 7Arend SM,Andersen P,van Meijgaarden KE,et al.Detection of active tuberculosis infection by T-cell response to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10.The Journal of Infectious Diseases,2000,181:1850-1854.
  • 8Dillon DC,Alderson MR,Day CH,et al.Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10,an immunodiagnostic antigen missing in Mycobacterium bovis BCG.J Clin Microbiol,2000,38:3285-3290.
  • 9Laurens AH,Van Pinxtern.Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10.Clinical and Diagnostic Laboratory Immunology,2000,3(7):155-160.
  • 10Lein AD,yon Reyn CF,Ravn P,et al.Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobaterium tuberculosis.Clin Diagn Lab Immunol,1999,6(4):606-609.

二级参考文献13

  • 1Mahairas G G, Sabo P J, hickey M J, et al. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M.bovis [J]. Bacteriol,1996,178:1274~1282.
  • 2Davin C D, Mark R A, Craig H D, et al. Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG [J]. Journal of Clinical Microbiology,2000,38(9):3285~3290.
  • 3Renshaw P S, Panagiotidou P, Whelan A, et al. CFP-10 complex implications for pathogenesis and virulence [J]. Biol Chem, 2002 , 277(24):21598~21603.
  • 4van Pinxteren L A H, Ravn P, Agger E M, et al. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10 [J]. Clinical and Diagnostic Laboratory Immunology, 2000, 7:155~160.
  • 5Bates J H The tuberculin skin test and preventative treatment for tuberculosis [J]. Tuberculosis, 1996,865~872.
  • 6Sandra M Arend, Peter Andersen, Krista E.van Meijgaarden, et al. Detection of active tuberculosis infection by T-cell response to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10 [J]. The Journal of Infectious Diseases, 2000,181:1850~1854.
  • 7Sorensen A L,Nagai S,Hou'en G, et al. Purification and characterization of a low molecular mass T-cell antigen secreted by Mycobacterium tuberculosis [J]. Infect Immune 1995,63:1710~1717.
  • 8Haslqvk, Andersen A B, Nagai S, et al.Guinea pig celluar immune responses to protein secreted by mycobacterium tuberculosis [J].Infect Immune, 1995,63:804~810.
  • 9Berthet F X,Rasmussen P B,Rosenkrands I, et al. A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10) [J]. Microbiology, 1998,144:3195~3203.
  • 10张灵霞,吴雪琼,史迎昌,梁建琴,张俊仙,张翠英.结核分支杆菌重组ESAT6蛋白抗原诱发豚鼠迟发型超敏反应的研究[J].中华结核和呼吸杂志,2001,24(6):383-384. 被引量:7

共引文献34

同被引文献15

  • 1World Health Organization. Global tuberculosis control - epidemiology, strategy, financing. WHO report 2009 (Geneva) , WHO/HTM/TB/2009,411.
  • 2Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skehon J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 1998,393 ( 6685 ):537-544.
  • 3Abdallah AM, Verboom T, Hanues F, Safi M, Strong M, Eisenberg D, Musters RJ, Vandenbroucke-Grauls CM, Appelmelk BJ, Luirink J, Bitter W. A speci? c secretion system mediates PPE41 transportin pathogenic mycobacteria. Molecular Microbiology, 2006, 62 ( 3 ) : 667-679.
  • 4Zhang SL, Zhao JW, Sun ZQ, Yang EZ, Yan JH, Zhao Q, Zhang GL, Zhang HM, Qi YM, Sun QW, Wang HH. Development and evaluation of a novel muhipleantigen ELISA for serodiagnosis of tuberculosis. Tuberculosis, 2009,89 ( 4 ) : 278-284.
  • 5Xu S, Yang Y, Jin R, Zhang M, Wang H. Purification and characterization of afunctionally active Mycobacterium tuberculosis prephenate dehydrogenase. Protein Expression and Purification, 2006,49 ( 2 ) : 151 - 158.
  • 6Kiefer Flofian, Arnold Konstantin, Kconzli Michael, Bordoli Lorenza, Schwede Torsten. The SWISS-MODEL Repository and associated resources. Nucleic Acids Research, 2009,37 ( 1 ) : D387-D392.
  • 7Jurgen Kopp, Torsten Schwede. The SWISS-MODEL Repository of annotated three-dimensional protein structure homology models. Nucleic Acids Research, 2004,32 : D230-D234.
  • 8Choudhary RK, Mukhopadhyay S, Chakhaiyar P, Sharma N, Murthy KJ, Katoch VM, Hasnain SE. PPE antigen Rv2430c of Mycobacterium tuberculosis induces a strong β-cell response. Infection and Immunity, 2003, 71 ( 11 ) :6338-6343.
  • 9Khan N, Alam K, Nair S, Valluri VL, Murthy KJ, Mukhopadhyay S. Association of Strong Immune Responses to PPE Protein Rv1168c with Active Tuberculosis. Clinical and Vaccine Immunology, 2008, 15(6) :974-980.
  • 10Zhang H, Wang J, Lei J, Zhang M, Yang Y, Chen Y, Wang H. PPE protein (Rv3425) from DNA segment RDll of Mycobacterium tuberculosis: a potential β-cell antigen used for serological diagnosis to distinguish vaccinated controls from tuberculosis patients. Clinical Microbiology and Infection, 2007,13 : 139-145.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部